Brzozowa M, Wyrobiec G, Kołodziej I, et al. The aberrant overexpression of vimentin is linked to a more aggressive status in tumours of the gastrointestinal tract. Gastroenterology Review/Przegląd Gastroenterologiczny. 2015;10(1):7-11. doi:10.5114/pg.2014.47502.
APA
Brzozowa, M., Wyrobiec, G., Kołodziej, I., Sitarski, M., Matysiak, N., & Reichman-Warmusz, E. et al. (2015). The aberrant overexpression of vimentin is linked to a more aggressive status in tumours of the gastrointestinal tract. Gastroenterology Review/Przegląd Gastroenterologiczny, 10(1), 7-11. https://doi.org/10.5114/pg.2014.47502
Chicago
Brzozowa, Marlena, Grzegorz Wyrobiec, Izabela Kołodziej, Mateusz Sitarski, Natalia Matysiak, Edyta Reichman-Warmusz, and Małgorzata Żaba et al. 2015. "The aberrant overexpression of vimentin is linked to a more aggressive status in tumours of the gastrointestinal tract". Gastroenterology Review/Przegląd Gastroenterologiczny 10 (1): 7-11. doi:10.5114/pg.2014.47502.
Harvard
Brzozowa, M., Wyrobiec, G., Kołodziej, I., Sitarski, M., Matysiak, N., Reichman-Warmusz, E., Żaba, M., and Wojnicz, R. (2015). The aberrant overexpression of vimentin is linked to a more aggressive status in tumours of the gastrointestinal tract. Gastroenterology Review/Przegląd Gastroenterologiczny, 10(1), pp.7-11. https://doi.org/10.5114/pg.2014.47502
MLA
Brzozowa, Marlena et al. "The aberrant overexpression of vimentin is linked to a more aggressive status in tumours of the gastrointestinal tract." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 10, no. 1, 2015, pp. 7-11. doi:10.5114/pg.2014.47502.
Vancouver
Brzozowa M, Wyrobiec G, Kołodziej I, Sitarski M, Matysiak N, Reichman-Warmusz E et al. The aberrant overexpression of vimentin is linked to a more aggressive status in tumours of the gastrointestinal tract. Gastroenterology Review/Przegląd Gastroenterologiczny. 2015;10(1):7-11. doi:10.5114/pg.2014.47502.
Vimentin is an intermediate filament protein normally expressed in cells of mesenchymal origin, e.g. myofibroblasts, chondrocytes, macrophages, and endothelial cells. The expression of vimentin, which has been thought of as the main mesenchymal marker, is also detected in tumour tissue. In tumours of the gastrointestinal tract vimentin expression is usually correlated with advanced stage of tumour, lymph node metastasis, and patient survival.
